Clinical Trial Update: Mavacamten in Adult Patients With Obstructive Hypertrophic Cardiomyopathy

View source ↗

Summary

The clinical trial update indicates that the mavacamten study in adults with obstructive hypertrophic cardiomyopathy has been completed, with results not disclo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertrophic Cardiomyopathy
• Obstructive Hypertrophic Cardiomyopathy

Drugs mentioned

• Mavacamten (mavacamten)

Snippet

Sponsor: Chinese Academy of Medical Sciences, Fuwai Hospital | Conditions: Hypertrophic Cardiomyopathy (HCM), Obstructive Hypertrophic Cardiomyopathy (oHCM) | Status: COMPLETED